This review evaluates phage therapy's mechanisms and strategies in treating multidrug-resistant infections, highlighting its implications for drug delivery and oncology.
Key Points
Phage therapy shows promise against multidrug-resistant infections, potentially transforming treatment strategies in clinical settings.
Clinical evidence supports phage efficacy across various infections, including respiratory, oral, wound, and urinary tract infections.
Challenges such as host range limitations and bacterial resistance indicate the need for ongoing research and development.
AI-driven optimization and interdisciplinary collaboration are essential for the successful translation of phage therapy into clinical practice.